SecBot SecBot
Insider Cluster (1 insider) ·Filed Feb 23, 2026

ARVN

ARVINAS, INC.
NEUTRAL
Impact 3/10
Horizondays Processed8mo ago
Insider cluster: 4 insiders, $0.1M total
Actionable Insight • Neutral

The level of insider selling is minimal and not concentrated, suggesting no strong negative signal. Traders should monitor for any escalation in selling volume or participation by C-suite executives.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$12.30
T+0 close · Feb 22, 2026 · via day close
Latest settled
−28.62%
T+60 · $8.78
Vs SPY
−36.87%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Feb 23 $12.30entry
  2. T+1 · 9mo ago +0.57%α −0.17% · $12.37
  3. T+5 · 9mo ago +8.86%α +8.24% · $13.39
  4. T+20 · 8mo ago −16.10%α −12.15% · $10.32
  5. T+60 · 6mo ago −28.62%α −36.87% · $8.78
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

An insider at Arvinas, Inc. (ARVN) sold 4,688 shares in an open-market transaction, generating proceeds of approximately $62,069. This brings the total insider selling over the past 30 days to $101K. The transaction is small relative to the company's $849M market cap and appears consistent with routine, pre-planned trading activity.

Key Financial Metrics

Direction
selling
Total Value
$62.1K
Insiders
1

Key Facts

  • Insider Houston John G sold 4,688 shares at $13.24 per share for total proceeds of $62,069.12
  • This was an open-market sale (Form 4 code 'S')
  • Total insider selling over the past 30 days amounts to $101K across 4 transactions
  • The total value of recent insider sales is less than 0.01% of Arvinas' $849M market capitalization

Financial Impact

$62,069 in open-market sales by one insider; $101K total over 30 days

insider ownershipshare count

Risk Factors

  • Continued insider selling, even at low levels, could signal muted confidence in near-term prospects
  • Biotech stocks like ARVN are inherently volatile and sensitive to clinical trial outcomes

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (1 trades, 7d window)cluster-ARVN-1772503070312

Track record

21 reports on ARVN

Performance horizon

6 of 9 bullish or bearish reports moved the stock their way by T+1. Best: +28.62% at T+60 after the Feb 23, 2026 report. 9 of 9 went positive at some point.

Filters
  1. Nov 3, 202613d ago S-3 Bearish 5/10 Entry $7.42 to $6.55 Now $6.77 +8.76% ▲ +11.73% +7.32% vs SPY
  2. Nov 3, 202613d ago 8-K Bearish 5/10 No price data
  3. Nov 3, 202613d ago Press Release Neutral 4/10 Entry $7.09 to $7.42 Now $6.77 −4.51% ▲ +4.65% +3.00% vs SPY
  4. Sep 4, 202610w ago 144 Neutral 3/10 Entry $9.08 to $8.76 Now $6.77 −25.44% ▼ −3.52% −3.06% vs SPY
  5. Jun 22, 202621w ago 8-K Neutral 3/10 Entry $8.14 to $8.05 Now $6.77 −16.83% ▼ −1.11% −1.06% vs SPY
  6. Jun 2, 202623w ago 8-K Bearish 6/10 Entry $7.70 to $7.74 Now $6.77 +12.08% ▼ −0.52% −0.12% vs SPY
  7. May 12, 202626w ago 8-K Mixed 6/10 No price data
  8. May 12, 202626w ago 8-K Bullish 7/10 Entry $9.57 to $9.87 Now $6.77 −29.26% ▲ +3.13% +2.56% vs SPY
  9. May 12, 202626w ago Press Release Bearish 8/10 Entry $9.57 to $9.87 Now $6.77 +29.26% ▼ −3.13% −2.56% vs SPY
  10. May 8, 202627w ago 144 Neutral 2/10 Entry $9.66 to $9.57 Now $6.77 −29.92% ▼ −0.93% −0.80% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens in 6h 22m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 2, 2026